(SXR4) iShares VII - iShares MSCI - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B52SFT06 • US Large-Cap Blend Equity
SXR4: Stocks, Equities, US, Large-Cap, Mid-Cap
The iShares VII PLC - iShares MSCI USA ETF USD Acc (XETRA:SXR4) is an exchange-traded fund designed to provide investors with exposure to large-cap and mid-cap companies in the United States. Listed on the XETRA exchange under the ticker symbol SXR4, this ETF is managed by BlackRock, one of the worlds largest asset managers. It seeks to replicate the performance of the Morningstar US Large-Mid NR USD index, which tracks a broad range of US equities.
With an assets under management (AUM) of 1347.03M EUR, this ETF offers a diversified portfolio of US stocks, blending large-cap and mid-cap companies. The fund is structured as a UCITS-compliant ETF, making it accessible to European investors while maintaining regulatory compliance. It is denominated in USD but traded on XETRA, allowing European investors to gain exposure to US equities without direct currency hedging.
Investors should note that this ETF does not provide direct information on key financial metrics such as P/E, P/B, or P/S ratios. These metrics are typically not disclosed for index-tracking ETFs, as the focus is on replicating the performance of the underlying index rather than actively managing the portfolio. The fund employs a replication strategy, meaning it aims to hold the same securities as the Morningstar US Large-Mid NR USD index in proportion to their weightings in the index.
For fund managers and investors, it is important to understand the underlying index and its construction. The Morningstar US Large-Mid NR USD index is designed to capture the performance of large-cap and mid-cap US equities, excluding small-cap companies. This makes the ETF suitable for investors seeking broad exposure to the US equity market, particularly those looking to diversify their portfolios with large-cap and mid-cap stocks.
As with any ETF, there are risks to consider. Market risk is inherent, as the funds performance is directly tied to the performance of the US equity market. Additionally, investors should be aware of the concentration risk, as the funds holdings are focused on US companies, which may be subject to sector-specific or regional economic fluctuations. Currency risk is also a factor, as the ETF holds assets in USD but is traded in EUR on XETRA, meaning currency movements can impact returns.
BlackRocks expertise in ETF management and the funds liquidity make it a popular choice for investors seeking efficient and cost-effective exposure to the US equity market. However, as with any investment, it is important to evaluate the funds objectives, risks, and fees in the context of your overall investment strategy.
Additional Sources for SXR4 ETF
SXR4 ETF Overview
Market Cap in USD | 1,477m |
Category | US Large-Cap Blend Equity |
TER | 0.07% |
IPO / Inception | 2010-01-12 |
SXR4 ETF Ratings
Growth 5y | 77.8% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength | -1.54 |
Analysts | - |
Fair Price Momentum | 430.51 EUR |
Fair Price DCF | - |
SXR4 Dividends
No Dividends PaidSXR4 Growth Ratios
Growth Correlation 3m | -73.1% |
Growth Correlation 12m | 78.4% |
Growth Correlation 5y | 90.6% |
CAGR 5y | 13.63% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 0.94 |
Alpha | -2.90 |
Beta | 0.921 |
Volatility | 20.50% |
Current Volume | 10.4k |
Average Volume 20d | 2.1k |
As of April 09, 2025, the stock is trading at EUR 471.06 with a total of 10,431 shares traded.
Over the past week, the price has changed by -10.42%, over one month by -12.18%, over three months by -19.70% and over the past year by -3.05%.
Yes. Based on ValueRay Analyses, iShares VII - iShares MSCI (XETRA:SXR4) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.75 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SXR4 as of April 2025 is 430.51. This means that SXR4 is currently overvalued and has a potential downside of -8.61%.
iShares VII - iShares MSCI has no consensus analysts rating.
According to ValueRays Forecast Model, SXR4 iShares VII - iShares MSCI will be worth about 477.4 in April 2026. The stock is currently trading at 471.06. This means that the stock has a potential upside of +1.35%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 477.4 | 1.4% |